Nutex Health Inc (NUTX) FinancialsNUTXFinancialNutex Health Inc

Nutex Health Inc (NUTX) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Hospital division, accounting for 95.9% of total sales, equivalent to $207.57M. Another important revenue stream is Population health management division. Understanding this composition is critical for investors evaluating how NUTX navigates market cycles within the Healthcare Facilities & Services industry.

Evaluating the bottom line, Nutex Health Inc maintains a gross margin of 67.04%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 57.75%, while the net margin is 45.70%. These profitability ratios, combined with a Return on Equity (ROE) of 57.16%, provide a clear picture of how effectively NUTX converts its operational activities into shareholder value.

In the context of the broader market, NUTX competes directly with industry leaders such as PNTG and GDRX. With a market capitalization of $1.28B, it holds a significant position in the sector. When comparing efficiency, NUTX's gross margin of 67.04% stands against PNTG's 12.91% and GDRX's 78.41%. Such benchmarking helps identify whether Nutex Health Inc is trading at a premium or discount relative to its financial performance.

Nutex Health has shown a remarkable turnaround in profitability with a net income of $65.8 million in Q2 2026, a substantial improvement from a loss of $17.7 million in the same quarter last year. The gross margin has also improved significantly, reaching 67.04% in Q2 2026, indicating strong operational efficiency.